Atlas Trials

A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19

Clinical trial NCT04421508 · TERMINATED

Trial details

NCT number
NCT04421508
Sponsor
Bellerophon Pulse Technologies
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
COVID-19CoronavirusCoronavirus Infection
Start date
2020-07-12
Primary completion
2020-12-28
Enrollment
191

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.